GREENOAKS CAPITAL MS LP - JENNER II SERIES (CIK: 0002019774) EDGAR, Information, Filings... CompaniesBIO.Com

GREENOAKS CAPITAL MS LP - JENNER II SERIES

Mailing address
4 ORINDA WAY, SUITE 200C, ORINDA, Delaware, 94563
Phone
415-942-5322
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

GREENOAKS CAPITAL MS LP - JENNER II SERIES (CIK: 0002019774) is an American company incorporated in the state of California. Head office is located at 4 ORINDA WAY, SUITE 200C, ORINDA, California, 94563. Work in the industry N/A. GREENOAKS CAPITAL MS LP - JENNER II SERIES is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by GREENOAKS CAPITAL MS LP - JENNER II SERIES

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002019774-24-000001 (33 Act) Size: KB	Apr-15-2024	021-510607 24843897

Recent 20 filings. View all GREENOAKS CAPITAL MS LP - JENNER II SERIES filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

GREENOAKS CAPITAL MS LP - JENNER II SERIES overview
GREENOAKS CAPITAL MS LP - JENNER II SERIES job
GREENOAKS CAPITAL MS LP - JENNER II SERIES stock
GREENOAKS CAPITAL MS LP - JENNER II SERIES ownership
GREENOAKS CAPITAL MS LP - JENNER II SERIES CEO
GREENOAKS CAPITAL MS LP - JENNER II SERIES documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.